Lesion Dosimetry for [177Lu] Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration …

M Grkovski, JA O'Donoghue, BS Imber… - Journal of Nuclear …, 2023 - Soc Nuclear Med
A single-institution prospective pilot clinical trial was performed to demonstrate the feasibility
of combining [177Lu] Lu-PSMA-617 radiopharmaceutical therapy (RPT) with stereotactic …

[PDF][PDF] Lesion Dosimetry for [177 Lu] Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic …

M Grkovski, JA O'Donoghue, BS Imber, G Andl, C Tu… - 2023 - researchgate.net
A single-institution prospective pilot clinical trial was performed to demonstrate the feasibility
of combining [177Lu] Lu-PSMA-617 radiopharmaceutical therapy (RPT) with stereotactic …

Lesion Dosimetry for [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration …

M Grkovski, JA O'Donoghue, BS Imber… - Journal of Nuclear …, 2023 - europepmc.org
A single-institution prospective pilot clinical trial was performed to demonstrate the feasibility
of combining [177 Lu] Lu-PSMA-617 radiopharmaceutical therapy (RPT) with stereotactic …

Lesion Dosimetry for [177Lu] Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration …

M Grkovski, JA O'Donoghue… - Journal of nuclear …, 2023 - pubmed.ncbi.nlm.nih.gov
A single-institution prospective pilot clinical trial was performed to demonstrate the feasibility
of combining [177 Lu] Lu-PSMA-617 radiopharmaceutical therapy (RPT) with stereotactic …

Lesion Dosimetry for [177 Lu] Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration …

M Grkovski, JA O'Donoghue, BS Imber, G Andl, C Tu… - J Nucl …, 2023 - Soc Nuclear Med
A single-institution prospective pilot clinical trial was performed to demonstrate the feasibility
of combining [177Lu] Lu-PSMA-617 radiopharmaceutical therapy (RPT) with stereotactic …